Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Migraine

Free Subscription Articles published in Lancet Retrieve available abstracts of 4 articles: HTML format

Single Articles

March 2025
1. VERSIJPT J, Paemeleire K, Reuter U, MaassenVanDenBrink A, et al
   Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives.
   Lancet. 2025;405:1014-1026.
   PubMed     Abstract available
   
   
   November 2023
2. DODICK DW, Goadsby PJ, Schwedt TJ, Lipton RB, et al
   Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
   Lancet. 2023 Nov 15:S0140-6736(23)01683-5. doi: 10.1016/S0140-6736(23)01683.
   PubMed     Abstract available
   
   
   July 2023
3. POZO-ROSICH P, Ailani J, Ashina M, Goadsby PJ, et al
   Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
   Lancet. 2023 Jul 26:S0140-6736(23)01049-8. doi: 10.1016/S0140-6736(23)01049.
   PubMed     Abstract available
   
   
   
4. HAANES KA, Edvinsson L
   Atogepant, the first oral preventive treatment for chronic migraine.
   Lancet. 2023 Jul 26:S0140-6736(23)01462-9. doi: 10.1016/S0140-6736(23)01462.
   PubMed    
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.